Champions Oncology (CSBR) Other Working Capital Changes (2010 - 2026)
Champions Oncology (CSBR) recorded quarterly Other Working Capital Changes of -$4.6 million in Q1 2026, down 583.85% quarter-over-quarter from -$675000.0 in Q4 2025, and down 623.95% on a YoY basis from $881000.0 in Q1 2025.
Champions Oncology (CSBR) Other Working Capital Changes (2010 - 2026) Analysis & Trends
Champions Oncology's Other Working Capital Changes history runs 17 years deep, the most recent figure standing at -$4.6 million for Q1 2026.
- In Q1 2026, Other Working Capital Changes fell 623.95% year-over-year to -$4.6 million; the TTM figure through Jan 2026 stood at -$4.6 million (down 106.19% YoY), while the FY2025 annual figure was -$144000.0, up 78.92% from the prior year.
- Other Working Capital Changes was -$4.6 million for Q1 2026 at Champions Oncology, down from -$675000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $2.4 million in Q1 2023 to a low of -$4.6 million in Q1 2026.
- Historically, Other Working Capital Changes has averaged -$244294.1 across 5 years, with a median of -$154000.0 in 2025.
- Biggest YoY gain for Other Working Capital Changes was 1502.34% in 2023; the steepest drop was 778.49% in 2023.
- A 5-year view of Other Working Capital Changes shows it stood at -$124000.0 in 2022, then surged by 975.0% to $1.1 million in 2023, then plunged by 108.48% to -$92000.0 in 2024, then tumbled by 633.7% to -$675000.0 in 2025, then slumped by 583.85% to -$4.6 million in 2026.
- The last three Other Working Capital Changes figures came in at -$4.6 million (Q1 2026), -$675000.0 (Q4 2025), and -$154000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Champions Oncology | 78.46 Mn | 71.46 Mn | 13.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | -4.62 Mn |
| Jan 31, 2026 | -4.62 Mn |
| Oct 31, 2025 | -675,000.00 |
| Oct 31, 2025 | -675,000.00 |
| Jul 31, 2025 | -154,000.00 |
| Jul 31, 2025 | -154,000.00 |
| Apr 30, 2025 | 849,000.00 |
| Apr 30, 2025 | 849,000.00 |
| Jan 31, 2025 | 881,000.00 |
| Jan 31, 2025 | 881,000.00 |
| Oct 31, 2024 | -92,000.00 |
| Oct 31, 2024 | -92,000.00 |
| Jul 31, 2024 | -1.78 Mn |
| Jul 31, 2024 | -1.78 Mn |
| Apr 30, 2024 | -1.24 Mn |
| Apr 30, 2024 | -1.24 Mn |
| Jan 31, 2024 | 1.10 Mn |
| Jan 31, 2024 | 1.10 Mn |
| Oct 31, 2023 | 1.09 Mn |
| Oct 31, 2023 | 1.09 Mn |